Peer Review History
| Original SubmissionJuly 7, 2021 |
|---|
|
PONE-D-21-22171Genomic diversity of bacteriophages infecting Rhodobacter capsulatus and their relatedness to its gene transfer agent RcGTAPLOS ONE Dear Dr. Alvey, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Though lengthy, the reviewer's points consist mostly of clarifications and addition of details necessary to fully appreciate the findings of the research presented in the manuscript. Please submit your revised manuscript by Oct 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Gabriel Moreno-Hagelsieb Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: “The research of JTB was supported by a grant (RGPIN 2018-03898) from the Canadian Natural Sciences and Engineering Research Council (NSERC). The research of DWB was supported by funds from the Illinois Wesleyan University Miner Linnaeus Sherff endowed professorship in Botany” Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The research of JTB was supported by a grant (RGPIN 2018-03898) from the Canadian Natural Sciences and Engineering Research Council (NSERC). The research of DWB was supported by funds from the Illinois Wesleyan University Miner Linnaeus Sherff endowed professorship in Botany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the study by Rapala and colleagues, the authors describe the isolation and characterisation of 26 phages infecting Rhodobacter capsulatus, a bacterial model for photosynthesis and nitrogen fixation for which phage discovery has been neglected for decades. The authors put particular emphasis on the genomic characterisation of the phage collection, placing the genomic sequences in the context of other R. capsulatus phages and the transfer agent RcGTA. The study presents a detailed analysis of new phage genomes, increasing the known diversity for R. capsulatus and providing information valuable for phage researchers interested in this bacterial model. Yet, several passages of the manuscript lack information relevant to understanding the context or the methods behind the results presented, thus affecting the reproducibility of the work. Below, I have listed a series of points that I consider require addressing. Major comments Line (L) 26. The authors claim the report of 26 new bacteriophages; however, only 21 genome accessions are provided and from Table 3, the Results and Methods sections, it is not clear which phages are reported and sequenced in this study. The authors should clarify this in a revised version of the manuscript in all relevant sections (including the abstract) and Figure/Table legends. L120-124. Indicate in the Table legend the number of virions measured. Likewise, as the table contains average values, include a value representing the level of variation amongst the measurements in parentheses. L128. Why/how the potential host strains were chosen? Are they representative of the species diversity? The methods lack critical information and precision, including Versions and settings of the software used (even if they were run on default settings this has to be indicated) Relevant cut-off values used to determine the sequence clusters and during the capsid and terminase BLASTp searches. The bioinformatics strategy to predict phage life style and determining the type of genome end. The latter being particularly important to support genome completeness. L178-180. The authors should consider repeating the search restricting the search set to viral sequences (e.g. Viruses (taxid:10239) or Caudovirales (taxid:28883)) in cases where no matches against phage genomes were found in the list of top 100 hits, and amend the relevant table and text if required. L182. In table 4, add the % of coverage and sequence identity of the reported matches. L190. “Very low numbers” is ambiguous, indicate the range of shared genes for singletons and in methods clarify what was the cut-off value to define them as such. Figures 3 and 4 are redundant regarding the primary information they provide. I suggest the authors keeping Figure 4 and sending Figure 3 to supplementary material. The manuscript contains an excessive number of genome comparisons as main figures, 7 in total (Figures 5-10 and 13). I encourage the authors to send these per-group comparisons to the supplementary material and compiling one main figure with the genome maps of the representatives of each group plus those of the singletons. Figure 13 displays relationships between some of the phages and RcGTA and can therefore stay as part of the main text. The authors should ensure that all Figures are provided in the optimal resolution before publication, as the current ones do not allow close inspection when zooming in. This is especially relevant for the text and numbers embedded in the genome maps. The authors report a diversity of GC content on the phage genomes sequenced. How do these different values compare to the GC content of the host genome? I recommend briefly discussing this topic in the relevant section of the manuscript. L600. What do the authors mean by “It was not able to be further cultivated”? No new plaques were generated on a bacterial lawn from a previous plaque? Please clarify. L649. Clarify in the figure legend what components and colours of the figure correspond to nucleotide or protein similarity and the minimum similarity value. L634. It is quite interesting that the authors did not find many homologs between RcGTA and the phages reported. Has RcGTA been previously compared to other phages? Briefly discuss this in the relevant section (e.g. L684-685). To ensure experiments reproducibility, it is essential that the authors provide information missing in the Methods section. In the growth and Isolation sub-section: Add how long you grew the phage hosts in both liquid and solid cultures, including the number of propagation steps. In the Lysogen testing sub-section: Indicate which host strains were used in these experiments; L729 - What PFU a “high titer lysate” corresponds to?; L733 and L736 - "After several days of incubation" and “several days until sufficiently grown” is ambiguous, state what the incubation period was and what sufficiently grown means (e.g. OD). In the Sequencing and annotation sub-section: L758 - Clarify the origin and titer of the phage sample; L767 - Was the Illumina library paired-end? Clarify. Indicate the range of genome coverage achieved. Minor comments Considering that R. capsulatus is a model for photosynthesis, did the authors search for phage-encoded genes potentially involved in this or other cellular processes important for the host? Such genes have been previously described in phages; hence, a brief sentence in the discussion would be of value to the reader interested in this topic. L101. Remove “gross” L116-118. In Figure 1, it can be implied that the phage cluster is indicated above the phage name, but it would be clearer if this is indicated in the figure legend. L131. Plaque morphology can be affected by several factors, and similar morphology does not guarantee sequence similarity. Thus, I recommend the authors focus this sentence on the patterns of plaque formation observed. L142. If the authors are referring to plaques that are not clear, “turbid” is a more standard term than “cloudy”. L157. Colour shades in the table are different from those used in figures. Overall, I consider the colours in the table unnecessary as the phage cluster is indicated. L195. In Figure 2, it would be useful to mark (e.g. with an asterisk) which genomes were available prior to this study to easily distinguish them from the ones reported in the paper. L220. Add the reference for Gepard in the figure legend. L226. What does DSMZ stand for? L231. Remove “phylogenomic” and clarify that the comparison was made at the nucleotide level (BLASTn). Indicate the minimum level of pairwise sequence similarity in the legend of figures displaying comparative genome maps. L285. Add a note indicating what “nkf” stands for. L473. Replace “lysogens” for “prophages” L521. “Myoviridae” shouldn’t be underscored. L625. Remove “:” L630. In Figure 13, both tail proteins are annotated as minor tail proteins. L645. Indicate similarity levels at nucleotide or protein level rather than stating “substantial similarity”. L663. What does the RMA and DWB abbreviations mean? L681. Add a reference for “a pattern commonly seen with studies of phages” L688-690. What is the role of the “peptidase”? L704-706. Add an appropriate reference to this statement. L712. Clarify how many phages reported in the study were isolated by the students. L772-775. This paragraph should be moved into the Genome comparisons section. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Genomic diversity of bacteriophages infecting Rhodobacter capsulatus and their relatedness to its gene transfer agent RcGTA PONE-D-21-22171R1 Dear Dr. Alvey, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Gabriel Moreno-Hagelsieb Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-22171R1 Genomic diversity of bacteriophages infecting Rhodobacter capsulatus and their relatedness to its gene transfer agent RcGTA Dear Dr. Alvey: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Gabriel Moreno-Hagelsieb Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .